Product
HPN424
Aliases
HPN424 1 Prime Step IV 225-300 ng/kg Target, HPN424 2 Prime Step IV 300 ng/kg Target, HPN424 2 Prime Step IV 450 ng/kg Target, HPN424 Fixed IV 1.3 to 150 ng/kg (1 other aliases)
Name
HPN424
1 clinical trial
1 drug
1 indication
Indication
Prostate CancerDrug
TrileukinClinical trial
A Phase 1/2a Open-label, Multicenter, Dose Escalation and Dose Expansion Study of the Safety, Tolerability, and Pharmacokinetics of HPN424 in Patients With Advanced Prostate Cancer Refractory to Androgen TherapyStatus: Terminated, Estimated PCD: 2023-02-27